{
  "schemaVersion": 1,
  "contentDigest": "16d57f6c19171d0795f84fb898188106f60a4c5660290fdd4101ccdbc345d1a9",
  "id": "news-oct22-a2-abu-dhabi-ai-drug-discovery-clinical-trials-2026-10-21",
  "language": "en",
  "interfaceLanguage": "en",
  "url": "https://voltformer.com/news/abu-dhabi-ai-drug-discovery-wearables-clinical-trials",
  "slug": "abu-dhabi-ai-drug-discovery-wearables-clinical-trials",
  "category": "policy-standards",
  "publishDate": "2026-10-21",
  "sourceName": "Emirates News Agency (WAM)",
  "sourceUrl": "https://www.wam.ae/en/article/c2us4jt-doh-signs-agreements-advance-research-life",
  "readingTimeMinutes": 1,
  "tags": [
    "United Arab Emirates",
    "Artificial intelligence",
    "Pharmaceuticals",
    "Clinical research"
  ],
  "content": {
    "title": "Abu Dhabi sets out AI drug research and clinical-trial plans",
    "summary": "Agreements include a 24-month roadmap and feasibility assessment of up to 30 trials by 2030.",
    "sections": [
      {
        "paragraphs": [
          "Abu Dhabi Health and Isomorphic Labs plan a 24-month roadmap for selected AI pre-clinical drug-discovery projects. The department, Cleveland Clinic Abu Dhabi and AstraZeneca will assess the feasibility of up to 30 trials by 2030. The agreements could deliver estimated life-sciences research investment of AED 180 million."
        ],
        "sources": [
          {
            "name": "Emirates News Agency (WAM)",
            "url": "https://www.wam.ae/en/article/c2us4jt-doh-signs-agreements-advance-research-life"
          }
        ]
      }
    ]
  },
  "companies": [],
  "sourceVersion": "1136537e0fc96c76f549839ff05cba5eba263c9ffb1cebd4444d8245de6848bb"
}